Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
Full-Text Search:
Chinese Journal of Lung Cancer
FQ: 月刊
AD of Publication: 天津市
Lanuage: 中文;
ISSN: 1009-3419
CN: 12-1395/R
YP: 1998
Url: 中国抗癌协会;中国防痨协会;天津医科大学总医院
Recommended Journals
Chinese Journal of Lung Cancer
2008 -01
Catalog
Construction of FasL siRNA expression vector and its expression in lung cancer cell line A549 WANG Haidong JIANG Yaoguang LIN Yidan WANG Ruwen DENG Bo Cardiothoracic Surgery,Southwest Hospi-tal,Third Military Medical University,Chongqing 400038,P.R.China;ΔChest Surgery Center of PLA,Daping Hospi-tal,Third Military Medical University,Chongqing 400042,P.R.China
The morphous analyses of three different characteristics cells growing in soft agar LIU Fangli YU Yang FU-Songbin.Laboratory of Medical Genetics,Harbin Medical University,Harbin,Heilongjiang 150081,China
Establishment and biological characteristics of a multi-drug resistant cell line A549/Gem WANG Weixia LIU Xiaoqing LIU Guangxian LIN Li ZHENG Xiaoling ZHU Yunfeng LI Xiaobing Lung Cancer Department in Tumor Center of PLA,Affiliated 307 Hospital,Academy of Military Medical Sciences,Beijing 100071,China
Expressions of Frat andβ-catenin in lung cancer and their clinicopathological correlations LUAN Lan ZHANG Yong GUO Ning WANG Enhuo,*Department of Pathology,College of Basic Medical Science,China Medical University,Shenyang,Liaoning 110001,China
Expression of ezrin in human lung carcinoma and its clinicopathologic significance LAN Lan SUN Tieying LIU Dongge PANG Jianxin YANG Li YANG Chunzheng XIONG Dongsheng.*Department of Graduate School,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China
Concurrent chemoradiotherapy with low-dose weekly docetaxel followed by consolidation chemotherapy with docetaxel and cisplatin in the treatment of stageⅢnon-small cell lung cancer LIU Xiaohong CHEN Hui XIAO Tianlin JIN Yiqiang CHEN Huaiyun.Department of Oncology,Xiangfan Cenral Hospital,Xiangfan,Hubei 441021,China
Expression of RhoE in lung and breast cancer and its clinical significance ZHU Yajie XU Feng ZHOU Ji-tao LIU Surui HUANG Juan LUO Deyun QIU Meng JIN Boquan BI Feng.Department of Abdominal Cancer,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China
Expression and clinical significance of caspase-3、survivin and k-ras in non-small cell lung cancer LI Chenghui HU Bing WANG Xiaoqui JI Chushu HE Yifu.*Department of Oncology,Affiliated Anqing Hospital of Anhui Medical university,Anqing,Anhui 246000,China
The value of serum tumor marker CA125 and CEA in the diagonosis of non-small cell lung cancer WANG Haiyan ZHU Zhengxue XIAO Yan MA Nan LI Hongmei WEN Zhong guang.*Respiratary Department,The First Affiliated Hospital,Gemeral Hospital of PLA,Beijing 100037,China
Analysis of prognostic factors in 352 lung cancer patients with brain metastases. Bai Hao Hart Baohui The Respiratory Department,Shanghai Chest Hospital,Shanghai Jiaotong University,Shanghai 200030,China
Preliminary investigation on expression of Bmi-1 in non-small-cellular lung cancer HU Zhonghua HU Yide ZHU yong.Center of Oncology,Xinqiao Hospital,The Third Military Medical University,Chongqing 400037,China
A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated ad-vanced non-small cell lung cancer ZHANG Shucai WANG Jinghui WANG Qunhui YANG Xinjie HU Fanbin LI Xi GU Yanfei WANG Haiyong.Department of medical oncology,Beijing Thoracic tumor and tuberculosis hos-pital,Beijing 101149,China
The expression and significance of indoleamine-2,3-dioxygenase in non-small cell lung cancer cell XIE Qichao WANG Lingli ZHU Bo WANG Yali GU Jianteng CHEN Zhengtang.The Institute of Cancer Research of Peo-pie "s Liberation Army,the Affiliated Xinqiao Hospital of Third Military Medical University,Chongqing 400037,Chi-na
Effects of MVP regimen on operation and cancer tisswes of Lung Cancer patients SHENTU Yang ZHENG Min CHEN Gang DING Zhengping ZHOU Yunzhang.*Department of Thoracic Surgery,Shanghai Chest Hospital,Shanghai lung tumor clinical medical center,Shanghai 200030,China
Expression of ER and AR in lung cancer YAN Ming CHEN Xiaobing WANG Shuling LI Yin.*Department of Thoracic Surgery,Henan Province Tumor Hospital,Zhengzhou,Henan 450008,China
The relationship between genetic polymorphism of GSTM1 and the outcome of chemotherapy in Chinese patients with primary lung cancer LI Weiying GU Yanfei LAI Baitang WANG Hui Beijing Thoracic Tumor and Tuberclosis Research Institute,Beijing 101149,China
Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma. WANG Yan ZHANG Xi-angru WANG Bin WANG Ziping CHU Datong SUN Yan.Department of Medical Oncology,Cancer lnstitue(Hospital),Chinese Aacademy of Medical Sciences & Peking Union Medical College,Beijing,100021,China
Advance of second-line chemotherapy in advanced non-small cell lung cancer Department of Medical Oncology:Cancer Center of Sun Yat-Sen University,Guangzhou,510060,China ZHANG Li,
Progress of clinical research in"tailor"chemotherapy for non-small-cell lung cancer Department of Medical Oncalogy:Beijing Hospital,Beijing 100730,China CHENG Gang
Correlation between the quantifiable parameters of blood flow pattern derived with dynamic CT in maliag-nant solitary pulmonary nodules and tumor size LI Shenjiang XIAO Xiangsheng IIU Shiyuan LI Huimin LI Chengzhou ZHANG Chenshi *Department of lmageology,The Eighty-eighth Military Hospital,Taian,Shan-dong 271000,China;ΔDepartment of Radiology,The Affiliated Changzheng Hospital,Shanghai No.2 Military Medi-cal University,Shanghai 200000,China
2008 Issues:  [01] [02] [03] [04] [05] [06]
More Issues:   [1998]   [1999]   [2000]   [2001]   [2002]   [2003]   [2004]   [2005]   [2006]   [2007]   [2009]   [2010]   [2011]   [2012]   [2013]   [2014]   [2015]   [2016]   [2017]
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved